GH-treated CKD and GH-treated sham mice exhibited significantly more average daily energy intake and weight gain compared to vehicle-treated CKD and vehicle-treated sham mice, respectively (Figure 1B,C). This evidence concerns the gene GH1 and chronic kidney disease.